The doctors faced a dilemma: The patient’s lungs were fueling the infection, but he was too sick to undergo a transplant ...
Spin-out Merge Labs aims to rival Elon Musk’s firm Neuralink. But researchers say the technology is still at an early stage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results